Diagnosis and management of coronary artery disease represents major challenges to our health care system, affecting millions of patients each year. Until recently, the diagnosis of coronary artery disease was possible only through cardiac catheterization and invasive coronary angiography. To avoid the risks of an invasive procedure, stress testing is often employed for an initial assessment of patients with suspected coronary artery disease, serving as a gatekeeper for cardiac catheterization. With the emergence of noninvasive coronary angiography, the question arises if such a strategy is still sensible, particularly, in view of only a modest agreement between stress testing results and the presence of coronary artery disease established by cardiac catheterization. Much data in support of the diagnostic accuracy and prognostic value of non-invasive coronary angiography by computed tomography have emerged within the last few years. These data challenge the role of stress testing as the initial imaging modality in patients with suspected coronary artery disease. This article reviews the clinical utility, limitations, as well as the hazards of stress testing compared with non-invasive coronary artery imaging by computed tomography. Finally, the implications of this review are discussed in relation to clinical practice.
CT angiography, stress testing, cardiac CT, coronary artery disease.
Armin Arbab-Zadeh, The Johns Hopkins Hospital, 600 N. Wolfe St/Blalock 524, Baltimore, MD 21287-0409, USA. Tel. +1.410.502.0549 – Fax: +1.443.287.6624. E-mail: firstname.lastname@example.org
Share this Article
Related Content In Heart Failure
A Personalized Approach to the Management of Congestion in Acute Heart Failure
Heart International. 2023;17(2):1–7:Online ahead of journal publication
Heart failure (HF), a prevalent disease, is the common final pathway of several conditions, which result in the activation of numerous neurohumoral pathways. Cardiorenal interaction plays an essential role in the progression of the disease, and the use of diuretics is a cornerstone in the treatment of hypervolemic patients, especially in acute decompensated HF (ADHF).1 The […]
Integrating Palliative Care into the Management of Heart Failure with Reduced Ejection Fraction: A Practice Pearl
Heart International. 2023;17(1):5–7 DOI: https://doi.org/10.17925/HI.2023.17.1.5
Palliative care (PC) is recommended as a standard of practice for all patients with heart failure (HF) and is supported by evidence of improved patient outcomes (e.g. reduction in symptoms refractory to cardiovascular therapies and improved shared decision-making).1 PC also addresses the persistent disparity in care experienced by patients from disenfranchised groups.2 PC is often a consultative […]
Measurement of Blood Volume in Patients with Heart Failure: Clinical Relevance, Surrogates, Historical Background and Contemporary Methodology
Heart International. 2023;17(1):36–44 DOI: https://doi.org/10.17925/HI.2023.17.1.36
Heart failure (HF) is a common clinical diagnosis often requiring hospitalization secondary to patient decompensation associated with clinically determined ‘dry’ or ‘wet’ volume states. However, fluid overload is the more common basis for clinical deterioration accounting for the majority of hospitalizations.1–4 There is often a cycle of decompensation, compensation following intervention and then a recurrence of volume overload […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!